Form 4 holding
Executive Chairperson, Director
Kyverna Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 66,741
- Estimated value
- $575,974
- Report date
- 27 May 2026
- Price
- $8.63
- Ownership
- Direct
Christi Shaw - Executive Chairperson, Director at Kyverna Therapeutics, Inc.
Issuer-level insider activity
- Role
- Executive Chairperson, Director
- Issuer symbol
- KYTX on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
No buys or sells have been reported by Christi Shaw since 03 Jun 2025
Reported holdings for Christi Shaw in Kyverna Therapeutics, Inc.
Form 4 holding
Executive Chairperson, Director
Kyverna Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 185,000
- Estimated value
- Report date
- 12 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Christi Shaw in Kyverna Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.